This is the authors' abstract. We don't add key points for this paper.
In our multicenter study, the incidence of germline mutations in genes mediating DNA-repair processes among men with metastatic prostate cancer was 11.8%, which was significantly higher than the incidence among men with localized prostate cancer. The frequencies of germline mutations in DNA-repair genes among men with metastatic disease did not differ significantly according to age at diagnosis or family history of prostate cancer. (Funded by Stand Up To Cancer and others.).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pritchard et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: